The primary objective of the study is to assess the dosis of DL which is sufficient to inhibit cold urticaria symptoms.
A total of 30 patients (male and female) with ACU will be included in this study
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
30
Every day,per mouth,in the evening, for 14 +- 2 days.
Department of Dermatology, Venerology and Allergology
Berlin, State of Berlin, Germany
CTTs and CSTTs assessed by TEMPtest 3.0 + urticaria network SOPs
Time frame: 6 weeks
Presence of wheal(s) at 4°C Intensity of pruritus and burning Number and duration of angioedemas QoL as assessed by DLQI Severity of ACU (by ACUSI)
Time frame: 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.